Daniel Steinberg to Immunosuppressive Agents
This is a "connection" page, showing publications Daniel Steinberg has written about Immunosuppressive Agents.
Connection Strength
0.177
-
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
Score: 0.079
-
Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
Score: 0.054
-
Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
Score: 0.016
-
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
Score: 0.015
-
Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol. 2007 Sep 15; 100(6):965-9.
Score: 0.014